Wintac’s promoter Veego Pharma, LLC has got approval from the Department of Pharmaceuticals (DoP), Ministry of Chemicals and Fertilizers, to hold up to 100 per cent shares in the company.
Veego has now been accorded the approval of the DOP vide letter dated March 13, 2020, for 100 per cent FDI, thereby enabling Veego to hold up to 100 per cent shares in the Company.
Wintac received letter dated March 13, 2020 from Veego informing about the receipt of DoP approval and conveying its intention to continue with the delisting process. The promoter further confirms that acquisition of shares from the public shareholders shall be made in accordance with the SEBI Delisting Regulations and that Veego will make a public announcement for the same.
Wintac is a professionally managed and fully integrated pharmaceutical company that is committed in developing, manufacturing and marketing of high quality pharmaceutical formulations using innovative technologies and meeting the cGMP standards which are continuously updated to international requirements.
